Delineating Swallowing Impairment and Decline in ALS
Public ClinicalTrials.gov record NCT02962050. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Delineating Physiologic Mechanisms of Swallowing Impairment and Decline in ALS
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to 1) evaluate the discriminant ability of simple clinical markers to detect swallowing impairment in individuals with ALS, 2) develop and validate a minimally invasive clinical screening tool for use at multidisciplinary ALS clinics, and 3) determine the natural history of swallowing impairment and decline in ALS.
Study identification
- NCT ID
- NCT02962050
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 109 participants
Conditions and interventions
Conditions
Interventions
- Videofluoroscopic Swallowing Study (VFSS) Procedure
- Voluntary Peak Cough Flow Testing Device
- Iowa Oral Performance Instrument Device
- Capsaicin Challenge Drug
- Pulmonary Function Testing Device
- Eating Assessment Tool 10 Other
- The Center for Neurologic Study Bulbar Function Scale Other
Procedure · Device · Drug + 1 more
Eligibility (public fields only)
- Age range
- 18 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 30, 2017
- Primary completion
- Feb 15, 2023
- Completion
- Feb 15, 2023
- Last update posted
- Feb 22, 2023
2017 – 2023
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Florida | Gainesville | Florida | 32605 | — |
| University of South Florida | Tampa | Florida | 33620 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02962050, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 22, 2023 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02962050 live on ClinicalTrials.gov.